These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21091931)

  • 21. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic.
    Schattenberg JM; Schuppan D
    Curr Opin Lipidol; 2011 Dec; 22(6):479-88. PubMed ID: 22002020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the metabolic syndrome to NAFLD or vice versa?
    Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
    Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Steatosis and steatohepatitis in diabetic patient].
    Hůlek P; Dresslerová I
    Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical spectrum and therapy of non-alcoholic steatohepatitis.
    Day CP
    Dig Dis; 2012; 30 Suppl 1():69-73. PubMed ID: 23075871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
    Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
    Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan.
    Okanoue T; Umemura A; Yasui K; Itoh Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():153-62. PubMed ID: 21199527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA; Feldstein AE
    J Dig Dis; 2011 Feb; 12(1):10-6. PubMed ID: 21091933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of the metabolic syndrome, 2002.
    Meigs JB
    Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic steatohepatitis: what we know in the new millennium.
    Harrison SA; Kadakia S; Lang KA; Schenker S
    Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.